{{Rsnum
|rsid=2764980
|Chromosome=10
|position=3284007
|Orientation=plus
|GMAF=0.4931
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 21.2 | 59.3 | 19.5
| HCB | 16.1 | 50.4 | 33.6
| JPT | 11.5 | 42.5 | 46.0
| YRI | 60.5 | 35.4 | 4.1
| ASW | 59.6 | 31.6 | 8.8
| CHB | 16.1 | 50.4 | 33.6
| CHD | 25.7 | 53.2 | 21.1
| GIH | 16.8 | 50.5 | 32.7
| LWK | 40.0 | 52.7 | 7.3
| MEX | 13.8 | 41.4 | 44.8
| MKK | 49.4 | 42.3 | 8.3
| TSI | 26.5 | 51.0 | 22.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=18951430
|Trait=Attention-deficit/hyperactivity disorder and conduct disorder
|Title=Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study
|RiskAllele=A
|Pval=0.000009
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs2764980
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18951430; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. (Initial Sample Size: 938 affected trios; Replication Sample Size: NR); (Region: 10p15.2; Reported Gene(s): PITRM1; Risk Allele: rs2764980-A); (p-value= 0.000009).This variant is associated with Attention-deficit/hyperactivity disorder and conduct disorder.
|Drugs=
|Drug Classes=
|Diseases=Attention Deficit Disorder with Hyperactivity
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740774
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2764980
|overall_frequency_n=62
|overall_frequency_d=128
|overall_frequency=0.484375
|n_genomes=34
|n_genomes_annotated=0
|n_haplomes=52
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}
{{on chip | Affy GenomeWide 6}}